Merck 2008 Annual Report Download - page 87

Download and view the complete annual report

Please find page 87 of the 2008 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 153

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153

Overall, the changes in the companies consolidated due to acquisitions had the follow-
ing effects on the consolidated balance sheet:
€ million
Acquisitions
Disposals/
Deconsoli-
dations
Pre-
acquisition
book value Adjustment Fair value
Disposal at
book value
Goodwill –26.726.7 –
Other intangible assets 0.4 30.6 31.0 –
Property, plant and equipment 1.1 –0.3 0.8 –
Other non-current assets 0.2 0.1 0.3 –
Cash and cash equivalents 4.3 – 4.3 –
Other current assets 3.4 1.6 5.0 –
Current and non-current liabilities 3.5 9.8 13.3 –
The acquisition of Bio-Fyt Pharma N.V, of Sint-Jans-Molenbeek, Belgium, was responsible
for € 14.8 million of the effect from the adjustment of goodwill. A further € 7.7 million
was due to the purchase of additional holdings in PT Merck Tbk of Jakarta, Indonesia.
€ 4.2 million resulted from the other named acquisitions.
The adjustment of other intangible assets primarily includes the purchase price alloca-
tion to brands, product rights, patents and technical know-how.
Taking into account the acquisitions made in 2008, sales and operating result were
impacted as follows in the reporting period:
€ million
Acquisitions/
First-time consolidations
Disposals/
Deconsolidations
Sales 1.4 –
Cost of sales –2.2 –
Other income/expenses –1.9 –
Operating result –2.7 –
82 | Merck Annual Report 2008